Trinity Biotech | TRIB - Operating Profit

Stock Price
0.72
Daily Change
-0.03 -3.87%
Monthly
-21.18%
Yearly
-11.78%
Q1 Forecast
0.69

Trinity Biotech reported $-509K in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Abbott USD 2.25B 73M Dec/2025
Bayer EUR -543M 556M Sep/2025
Bio-Rad Laboratories USD 63.9M 13.2M Sep/2025
EDAP TMS EUR -5.77M 228K Jun/2025
J&J USD 5.59B 1.81B Dec/2025
Mesa Laboratories USD 5.78M 2.27M Dec/2024
OraSure Technologies USD -6M 3.26M Sep/2024
Roche Holding CHF 9.56B 3.8B Dec/2025
Siemens EUR 2.57B 3M Dec/2025
Surmodics USD -5.64M 276K Sep/2024
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Tosoh JPY 25.15B 3.51B Dec/2025
Trinity Biotech USD -509K 6.27M Sep/2025
Veracyte USD 24.63M 1.52M Dec/2025